J. Andrew_Case

J. Andrew Case

Head of Clinical Supply Chain - Individualized Therapies, Genentech

Previously global business owner managing the Novartis business solution for the first to market CAR-T therapy. Subject matter expert in CAR-T Chain of Identity, order management, international supply chain solutions and technology development. Leading engagement with cellular therapy contract manufacturers as well as enabling commercial launches in 28 countries and counting.

Appearances